Volume 12 - July 2025

Explore Brisbane from Above at the ISDE 2025 Congress Dinner


Join us on September 19, 2025, for an unforgettable evening at the BCEC’s Sky Room & Terrace. Overlooking the sparkling city skyline, this special event offers the perfect blend of breathtaking views, exceptional Australian cuisine, and lively entertainment.

 

Congress Dinner Details:

Date: September 19, 2025

Time: 7:00 PM – 10:00 PM

Location: Sky Room & Terrace – Brisbane Convention & Exhibition Centre

Fee: $165 USD per person

Dress Code: Business Casual


Registration Details Here

We are pleased to welcome our newest ISDE Members to the global esophageal community!


Your commitment to advancing education, research, and collaboration in esophageal diseases strengthens our shared mission. We’re excited to have you on board and look forward to the impact you’ll make. Welcome to ISDE!


Since July 1st, 11 new members from 6 different countries have joined our community, bringing expertise in gastroenterology, oncology, and surgery. Their names and a world map highlighting their countries are featured below, reflecting our growing international reach.

Matthew Allaway (Australia)

Naveena Kumar (India)

Ernest Chan (USA)

Renato Dr Martino (Italy)

Shun Ito (Japan)

Shun Ito (Japan)

Andrei Moscalu (UK)

Ryan Newbold (Australia)

Valentina Infusino (Italy)

Aadil Rahim (Australia)

Unaiza Waheed (UK)



Wilson Jing Peng (Australia)

Announcing Jessie Elliott as

Editor, Young DOTE

ISDE is delighted to announce Dr. Jessie Elliott as the inaugural Editor of Young DOTE, a new role within the Diseases of the Esophagus (DOTE) journal.


In this role, Jessie will:


  • Launch a “Lessons Learned” section featuring practical insights on techniques and training pathways for early-career professionals
  • Engage early-career professionals in DOTE’s editorial process
  • Support ISDE’s mission to develop the next generation of global leaders in esophageal care


Dr. Elliott is a Consultant Upper GI Surgeon and Principal Investigator at Trinity St. James’s Cancer Institute in Dublin. Her research focuses on cancer survivorship, nutrition, and clinical trials, and she holds multiple leadership and mentoring roles.

We are excited to welcome Jessie and look forward to her leadership in shaping the future of Young DOTE.


See full article here

DOTE - Volume 38, Issue 4, July 2025 The latest issue of Diseases of the Esophagus Journal is now available online.

Table of Contents:


Systematic Review and Meta-Analysis



Original Articles









Lessons Learned



Subscribe to Email Alerts

Members and Subscribers Article


Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett’s esophagus


  • Barrett’s esophagus affects up to 5.4% of Australians and 3% of USA Whites — much higher than previous estimates.


  • Prevalence increases with age: from 0.05% under 30 years to 12% over 75 years.


  • Australian males show the highest prevalence at 7.4%, peaking at 14% after 75 years.


  •  USA females have the lowest prevalence at just 1%.


  • Lifetime esophageal cancer risk: 0.81% in Australia and 0.56% in the USA.


  • Over 90% of esophageal adenocarcinoma cases occur without prior diagnosis of Barrett’s esophagus.


  • If Barrett’s prevalence were truly 1%, 30–45% would develop cancer — clearly implausible.


  • True prevalence is likely 3-5 times higher than currently reported.


  • Monte Carlo simulations (10,000 iterations) confirm robust, age-specific estimates.


  • Findings support more targeted screening in older males to prevent missed cases.

See full article here

A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients


  • Hospitals treating more patients with curative intent for esophageal or gastric cancer show better quality-adjusted survival — at no significant extra cost.


  • Cost per QALY is lowest in hospitals with higher curative intent treatment rates for both esophageal and gastric cancer.


  • Higher curative intent in cancer care leads to better outcomes with only small differences in healthcare costs.


  • For potentially curable GI cancers, treating more like high-curative intent hospitals improves both life expectancy and cost-effectiveness.


  • Hospitals with higher rates of curative treatment deliver the best value for money in esophageal and gastric cancer care.


  • Treating potentially curable esophageal & gastric cancers with high curative intent is consistently cost-effective


  • Quality of care matters: Hospitals with higher curative treatment rates offer the best survival gains at modest cost differences.

See full article here

Literature Updates

Multidose Ondansetron after Emergency Visits in Children with Gastroenteritis


Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer


Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy


Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer


Diagnostic Accuracy of Timed Barium Esophagram for Achalasia


Gastrointestinal Tissue Eosinophil Quantification in Healthy Adult Volunteers


Worldwide survey on the transcervical approach for minimally invasive treatment of esophageal cancer: results of questionnaire of the international collaborative group on transCervical Minimally Invasive Esophagectomy 



Visit the ISDE Literature Updates Online for more.

 

AANZGOSA Annual Scientific Meeting 2025 - September 17, 2025 in Brisbane


21st ISDE World Congress - September 18-20 in Brisbane, Australia


MIGES 2025 - October 6-7 in Singapore


Additional events of interest to the ISDE members and community can be found on the ISDE Events Calendar.

 
Follow ISDE on Social Media
Facebook  Twitter  Youtube  Instagram  
CONTACT US: membership@isde.net | 604.638.3862
All communications will generally come from membership@isde.net, please be aware of spam/malicious emails using ISDE information.